Home › Insurance › Prescription drug prices (CPI)
Direct answer: Yes, by the Bureau of Labor Statistics' measure. The Consumer Price Index for prescription drugs fell 1.2% from August to September 2026 and 4.5% from September 2025, to 543.556. It tracks the total price pharmacies receive from patients and insurers combined, not what each household pays out of pocket.
By the numbers: September 2026 index 543.556, down from 550.410 in August 2026 and 569.046 in September 2025 (1982-84=100); the lowest reading since December 2022. Source: U.S. Bureau of Labor Statistics, CPI release (Oct. 14, 2026)
“The tracked price is the total reimbursement to the retailer from the patient and all eligible payers for a single prescription.” — BLS, Measuring Price Change in the CPI: Medical care
Updated 2026-10-17
By the BLS measure, yes. The CPI-U prescription drugs index fell 1.2% from August and 4.5% from September 2025, to 543.556 (1982-84=100). Overall consumer prices rose 3.7% over the same 12 months.
BLS doesn't seasonally adjust this index; its tables mark prescription drugs "not seasonally adjusted." The seasonally adjusted series (CUSR0000SEMF01) carries the same values as the unadjusted one (CUUR0000SEMF01), so the monthly change is -1.2% either way.
Not necessarily. The index tracks the total price the pharmacy receives from you plus your insurer or Medicare Part D plan. Your copay or coinsurance depends on your plan's design, deductible and drug list, which can move differently.
Prescriptions filled at retail, mail-order and internet pharmacies and paid by cash, private insurance or Medicare Part D. Medicaid isn't included, manufacturer rebates aren't subtracted, and drugs given during hospital visits count under hospital services (BLS).
Enter your own drug list in Medicare Plan Finder and compare plans between Oct. 15 and Dec. 7, 2026; changes start Jan. 1, 2027. In 2027 every Part D plan's deductible is capped at $700 and out-of-pocket costs for covered drugs at $2,400.
BLS schedules the October 2026 CPI for Tuesday, Nov. 10, 2026, at 8:30 a.m. Eastern.
As of Oct. 17, 2026 · BLS CPI for September 2026 (released Oct. 14, 2026) · next CPI Nov. 10, 2026
Use open enrollment (Oct. 15 – Dec. 7, 2026) to compare plans on your own drug list. The CPI shows the average total price fell; your own cost depends on your plan. Enter your drugs and pharmacy in Medicare Plan Finder, then check the 2027 limits and costs on our Part D page.
The math:
Sources: BLS CPI release, Sept. 2026 · VaultRubric Part D 2027 · Medicare.gov: Joining a plan
A best fit for the situation described, not financial advice or a buy/sell recommendation. Partner links never change a pick.
The CPI is an index (1982-84 = 100), so the percent change between two months is the difference divided by the earlier month, the same formula BLS shows in its technical note.
(543.556 − 550.410) ÷ 550.410 × 100 = -1.245% → rounds to −1.2%(543.556 − 569.046) ÷ 569.046 × 100 = -4.479% → rounds to −4.5%Sources: BLS CPI release, Sept. 2026 · BLS CPI table 2 · BLS series CUUR0000SEMF01 · BLS series CUSR0000SEMF01
| Month | Index (1982-84=100) | vs. prior month | vs. a year earlier |
|---|---|---|---|
| Sept. 2026 | 543.556 | −1.2% | −4.5% |
| Aug. 2026 | 550.410 | 0.0% | −2.9% |
| July 2026 | 550.590 | −0.8% | −3.1% |
| June 2026 | 554.886 | −0.1% | −2.5% |
| May 2026 | 555.276 | −0.9% | −2.0% |
| April 2026 | 560.317 | 0.0% | −0.5% |
| March 2026 | 560.172 | −1.5% | −0.2% |
| Feb. 2026 | 568.742 | −0.2% | −0.7% |
| Jan. 2026 | 569.610 | 0.0% | −0.5% |
| Dec. 2025 | 569.656 | +0.1% | +2.0% |
| Nov. 2025 | 568.885 | n/a | +1.9% |
| Oct. 2025 | not published | n/a | n/a |
| Sept. 2025 | 569.046 | +0.3% | +1.7% |
| Aug. 2025 | 567.117 | −0.2% | +0.9% |
| July 2025 | 567.975 | −0.2% | +0.9% |
| June 2025 | 569.098 | +0.4% | +1.2% |
| May 2025 | 566.716 | +0.6% | +0.8% |
| April 2025 | 563.253 | +0.4% | +2.3% |
| March 2025 | 561.202 | −2.0% | +2.1% |
| Feb. 2025 | 572.748 | 0.0% | +4.6% |
| Jan. 2025 | 572.655 | +2.5% | +4.5% |
| Dec. 2024 | 558.744 | 0.0% | +1.1% |
| Nov. 2024 | 558.497 | −0.4% | +0.7% |
| Oct. 2024 | 560.836 | +0.2% | +1.6% |
BLS series CUUR0000SEMF01 (U.S. city average, all urban consumers). Changes are computed from the published index levels and match BLS’s published one-decimal figures. October 2025 was not published (BLS: “Data unavailable due to the 2025 lapse in appropriations”), so November 2025’s monthly change and October 2025’s yearly change show n/a. Sources: BLS series CUUR0000SEMF01 · BLS CPI release, Sept. 2026
“The prescription drugs index measures price change of drugs purchased with a prescription at a retail, mail order, or internet pharmacy. The tracked price is the total reimbursement to the retailer from the patient and all eligible payers for a single prescription.” — BLS
Source: BLS CPI medical care methodology (paraphrased except the quote).
A falling index doesn’t tell you what you’ll pay at the counter. Your cost depends on your plan’s premium, deductible, drug list and copays. If you have Medicare, the 2027 numbers on our Medicare Part D 2027 page set the limits:
15 drugs with Medicare negotiated prices from Jan. 1, 2027 (prices Medicare drug plans pay for a 30-day supply, not your copay; they start after the September 2026 data above):
| Drug | 2027 negotiated, 30 days | 2024 list price | Discount |
|---|---|---|---|
| Ozempic; Rybelsus; Wegovy | $274 | $959 | 71% |
| Trelegy Ellipta | $175 | $654 | 73% |
| Xtandi | $7,004 | $13,480 | 48% |
| Pomalyst | $8,650 | $21,744 | 60% |
| Ofev | $6,350 | $12,622 | 50% |
| Ibrance | $7,871 | $15,741 | 50% |
| Linzess | $136 | $539 | 75% |
| Calquence | $8,600 | $14,228 | 40% |
| Austedo; Austedo XR | $4,093 | $6,623 | 38% |
| Breo Ellipta | $67 | $397 | 83% |
| Xifaxan | $1,000 | $2,696 | 63% |
| Vraylar | $770 | $1,376 | 44% |
| Tradjenta | $78 | $488 | 84% |
| Janumet; Janumet XR | $80 | $526 | 85% |
| Otezla; Otezla XR | $1,650 | $4,722 | 65% |
Sources: VaultRubric Part D 2027 · Medicare.gov: Joining a plan. Full details, a cost calculator and plans by state are on the Part D page.
Numbers only. This page reports BLS data and BLS’s own description of its methods. It doesn’t credit or blame any administration, law or program, and it isn’t insurance or medical advice. Free, unbiased Medicare help: your State Health Insurance Assistance Program (SHIP) or 1-800-MEDICARE.
By the BLS measure, yes. The CPI-U prescription drugs index fell 1.2% from August and 4.5% from September 2025, to 543.556 (1982-84=100). Overall consumer prices rose 3.7% over the same 12 months.
BLS doesn't seasonally adjust this index; its tables mark prescription drugs "not seasonally adjusted." The seasonally adjusted series (CUSR0000SEMF01) carries the same values as the unadjusted one (CUUR0000SEMF01), so the monthly change is -1.2% either way.
Not necessarily. The index tracks the total price the pharmacy receives from you plus your insurer or Medicare Part D plan. Your copay or coinsurance depends on your plan's design, deductible and drug list, which can move differently.
Prescriptions filled at retail, mail-order and internet pharmacies and paid by cash, private insurance or Medicare Part D. Medicaid isn't included, manufacturer rebates aren't subtracted, and drugs given during hospital visits count under hospital services (BLS).
Enter your own drug list in Medicare Plan Finder and compare plans between Oct. 15 and Dec. 7, 2026; changes start Jan. 1, 2027. In 2027 every Part D plan's deductible is capped at $700 and out-of-pocket costs for covered drugs at $2,400.
BLS schedules the October 2026 CPI for Tuesday, Nov. 10, 2026, at 8:30 a.m. Eastern.
Facts, not insurance advice. We don't sell insurance or provide quotes; confirm coverage and requirements with the insurer, an agent or your state insurance department.